Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer
JAMA Oncol
.
2020 Jul 1;6(7):1115.
doi: 10.1001/jamaoncol.2020.0631.
Authors
Tao Wang
1
,
Shiowjen Lee
2
,
Gerald M Feldman
1
Affiliations
1
Office of Biotechnology Products, Center for Drug Evaluation and Research, Silver Spring, Maryland.
2
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
PMID:
32352495
DOI:
10.1001/jamaoncol.2020.0631
No abstract available
Publication types
Letter
Comment
MeSH terms
Apoptosis
Humans
Immune Checkpoint Inhibitors*
Immunotherapy
Ligands
Neoplasms* / drug therapy
Substances
Immune Checkpoint Inhibitors
Ligands